Signaling pathways
-
F1622 Anti-Syndecan-1/CD138 Antibody (Indatuximab)Summary: Anti-Syndecan-1/CD138 Antibody (Indatuximab) -
F1623 Anti-TCR Antibody (TOL101)Summary: Anti-TCR Antibody (TOL101) -
F1624 Anti-TNFSF12/TWEAK Antibody (RO5458640)Summary: Anti-TNFSF12/TWEAK Antibody (RO5458640) -
F1625 Anti-TNFSF1/TNFb/ LT alpha Antibody (Pateclizumab)Summary: Anti-TNFSF1/TNFb/ LT alpha Antibody (Pateclizumab) -
F1626 Anti-TCR Antibody (NKTT320)Summary: Anti-TCR Antibody (NKTT320) -
F1627 Anti-TLR3/CD283 Antibody (CNTO5429)Summary: Anti-TLR3/CD283 Antibody (CNTO5429) -
F1628 Anti-TLR7 Antibody (U.Tokyo patent anti-TLR7)Summary: Anti-TLR7 Antibody (U.Tokyo patent anti-TLR7) -
F1629 Anti-FOLH1/PSMA Antibody (PelgifatamAb)Summary: Anti-FOLH1/PSMA Antibody (PelgifatamAb) -
F1630 Anti-MU5AC Antibody (Ensituximab)Summary: Anti-MU5AC Antibody (Ensituximab) -
F1631 Anti-PCSK9 Antibody (Boehringer anti-PCSK9)Summary: Anti-PCSK9 Antibody (Boehringer anti-PCSK9)